KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EPS (Weighted Average and Diluted) (2016 - 2025)

Merck (MRK) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $1.19 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 19.59% to $1.19 in Q4 2025 year-over-year; TTM through Dec 2025 was $7.28, a 8.17% increase, with the full-year FY2025 number at $7.28, up 8.01% from a year prior.
  • EPS (Weighted Average and Diluted) was $1.19 for Q4 2025 at Merck, down from $2.32 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.32 in Q3 2025 to a low of -$2.35 in Q2 2023.
  • A 5-year average of $1.25 and a median of $1.38 in 2024 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 251.61% in 2023, then surged 408.33% in 2024.
  • Merck's EPS (Weighted Average and Diluted) stood at $1.2 in 2021, then decreased by 1.67% to $1.18 in 2022, then crashed by 140.68% to -$0.48 in 2023, then soared by 408.33% to $1.48 in 2024, then fell by 19.59% to $1.19 in 2025.
  • Per Business Quant, the three most recent readings for MRK's EPS (Weighted Average and Diluted) are $1.19 (Q4 2025), $2.32 (Q3 2025), and $1.76 (Q2 2025).